Similar Articles
921 Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
922 Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma
923 Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma
924 Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma
925 Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
926 Current status and perspectives of immune-based therapies for hepatocellular carcinoma
927 Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
928 Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
929 Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
930 Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA